Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes. - Test2 - elhamkhani - TriplyDB

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.

http://www.wikidata.org/entity/Q37684619

about

The early metabolomic response of adipose tissue during acute cold exposure in mice.Curcumin suppresses gastric tumor cell growth via ROS-mediated DNA polymerase γ depletion disrupting cellular bioenergetics.T-cell Metabolism as a Target to Control Autoreactive T Cells in β-Cell Autoimmunity.Glutamine Metabolism in Cancer: Understanding the Heterogeneity.Glutaminolysis gets the spotlight in cancer Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.Targeted inhibition of glutaminase as a potential new approach for the treatment of NF1 associated soft tissue malignancies.Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.

P2860

Q33799403-B74252BD-DB8F-4A89-A64E-D58D9456D756 Q37731658-F8A098EE-A9BB-448D-A548-A4D1574C9DA1 Q39183146-69345905-70A0-4CC7-BFE8-664F25380BD1 Q39230796-B84FFD04-699F-4712-84E1-85FC44F6C103 Q42315750-48A6435D-518F-4518-B9FA-2DA820739BB5 Q46300745-A3D6FB69-91D7-447E-960D-4B82ECEA0175 Q49367042-9CB507F9-F1EF-4BE5-9344-C093B7F14ED0 Q50033966-6FC7852E-E7AE-495E-8236-E0947EC1E165

P2860

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.

http://www.wikidata.org/entity/Q37684619

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Inhibiting glutaminase in acut ...... ency of selected AML subtypes.

@en

Inhibiting glutaminase in acut ...... ency of selected AML subtypes.

@nl

type

label

Inhibiting glutaminase in acut ...... ency of selected AML subtypes.

@en

Inhibiting glutaminase in acut ...... ency of selected AML subtypes.

@nl

prefLabel

Inhibiting glutaminase in acut ...... ency of selected AML subtypes.

@en

Inhibiting glutaminase in acut ...... ency of selected AML subtypes.

@nl

P1433

Q37684619-B61DD426-C891-4EAE-9ABE-3866805DA79D

P1476

Q37684619-8464220C-84A5-4FCE-9E42-98ADA923B48A

P2093

Q37684619-066490D4-5FA8-4740-A926-DC7B5288E445

Q37684619-0E9391BE-9E9B-4099-B143-CB45AFF6157E

Q37684619-15BDAF3F-1D58-413F-82EB-D1E0E719DAF0

Q37684619-22C3223A-3E12-452D-B487-E5FB88110036

Q37684619-25C5D279-99EB-4BB3-9450-A5CC40931D98

Q37684619-2FBB847C-AC4A-4548-B104-5B24C956134E

Q37684619-35A972BD-37BD-42DB-AD94-E8BEBCC409B5

Q37684619-37D4269E-0455-4854-913F-50E5BC72DD81

Q37684619-38885BCB-4FC0-4088-BB7B-5D46A6A4B9EC

Q37684619-40D8FF6E-7325-4BEC-9480-200F62ACB443

P2860

Q37684619-010AD569-7B81-41B6-89D4-91C8B3B44F58

Q37684619-010C052A-C824-41E7-8809-B3F70339CA85

Q37684619-0718B855-E8E0-4A2A-AE91-F78E4E1E4EB5

Q37684619-14997D48-1C5C-4F9B-B4C8-BD23C9481823

Q37684619-16C12CC8-192C-48B1-B279-1503D7D41A0D

Q37684619-1ED9BCDB-FAD3-46D1-AE7F-8CEEC0C0AC43

Q37684619-23F8596D-FBB6-4922-B197-39D2FE4B1794

Q37684619-2E6FF431-0184-4AD3-839B-D0DC60C643A4

Q37684619-37CD2C9A-8128-4A9E-AE5A-2041DB98D112

Q37684619-41E1DAE4-FF31-45B7-9213-EA4400FA68BE

P304

Q37684619-303165EC-FD77-47F4-B95C-4E61A17E2E3F

P31

Q37684619-F2AA3404-EC35-47BF-ADC0-1264B877FE11

P356

Q37684619-856AA137-2063-446C-B536-7B8A2C649E90

P407

Q37684619-6F52342D-0A49-47A1-BCD1-58B200001682

P433

Q37684619-44797745-6883-46EF-AF8C-A846146DB888

P478

Q37684619-99429A0B-8699-4CAF-BBD7-C662E0DC805B

P50

Q37684619-A314236B-942C-4CA6-BF24-1AF0B21C70B5

Q37684619-DC942BFD-8AD1-4264-BCEF-24DFE4E4D9AC

P577

Q37684619-226DBBC3-C4C7-4988-BDCF-1F3A97FAC2E4

P698

Q37684619-F34AD851-6FCF-4304-8AAC-CA75A0555203

P921

Q37684619-561C3398-5043-4CBD-B82F-14A2CB469A2B

P932

Q37684619-21A44620-0AE1-4B71-B89D-EED34D97E203

P356

ONCOTARGET.12944

P1433

P1476

Inhibiting glutaminase in acut ...... ency of selected AML subtypes.

@en

P2093

Aaron D Schimmer

http://www.w3.org/2001/XMLSchema#string

Alessia Lodi

http://www.w3.org/2001/XMLSchema#string

Courtney DiNardo

http://www.w3.org/2001/XMLSchema#string

Doriann Gonzalez

http://www.w3.org/2001/XMLSchema#string

Elsa Renee Flores

http://www.w3.org/2001/XMLSchema#string

Helen Ma

http://www.w3.org/2001/XMLSchema#string

Ismael Samudio

http://www.w3.org/2001/XMLSchema#string

Juliana Velez

http://www.w3.org/2001/XMLSchema#string

Natalia Baran

http://www.w3.org/2001/XMLSchema#string

Polina Matre

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids

Full-length human glutaminase in complex with an allosteric inhibitor

A scaling normalization method for differential expression analysis of RNA-seq data

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

Metabolomics in rheumatic diseases: desperately seeking biomarkers

Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

FeII/alpha-ketoglutarate-dependent hydroxylases and related enzymes

Expanding chemical biology of 2-oxoglutarate oxygenases

Inhibition of 2-oxoglutarate dependent oxygenases

P304

79722-79735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12944

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Torsten Haferlach

Marina Konopleva

P577

2016-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27806325

http://www.w3.org/2001/XMLSchema#string

P921

P932

5340236

http://www.w3.org/2001/XMLSchema#string